Lv2
142 积分 2026-02-05 加入
CHK1 siRNA Containing Gemcitabine and Chemically Modified Nucleotides Shows Antitumoral Activity in Vitro and in Vivo
1个月前
已完结
Bispecific antibody boosts dendritic cell-T cell crosstalk
2个月前
已完结
A bioengineered antibody conjugate reshape dendritic cell viability for immune-tolerance modulation
2个月前
已完结
A bioengineered antibody conjugate reshape dendritic cell viability for immune-tolerance modulation
2个月前
已完结
Identification of a novel DEC-205 binding peptide to develop dendritic cell-targeting nanovaccine for cancer immunotherapy
2个月前
已完结
Identification of a novel DEC-205 binding peptide to develop dendritic cell-targeting nanovaccine for cancer immunotherapy
3个月前
已完结
A new regulatory axis in cross-presentation: MS4A7 licenses cDC1s for effective CD8+ T-cell priming
3个月前
已完结
Agonistic anti-CD40 antibody treatment converts resident regulatory T cells into activated type 1 effectors within the tumor microenvironment
6个月前
已完结
The tetraspan MS4A family in homeostasis, immunity, and disease
7个月前
已完结
Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity
7个月前
已完结
皖公网安备34019202002308
